Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omegaven for Parenteral Nutrition Associated Cholestasis
NCT00969332Phase 2Terminated
- Sponsor
- University of California, Los Angeles
- Start
- Aug 2009
- Primary completion
- Jan 2019
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of eicosapentaenoic acid + docosahexaenoic acid in parenteral nutrition-associated cholestasis (PNAC), sponsored by University of California, Los Angeles. Started Aug 2009; status: terminated.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
parenteral nutrition-associated cholestasis (PNAC)
Beyond the preview
Go deeper on NCT00969332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00969332.